Preclinical antitumor activity of ST7612AA1: a novel second generation oral histone deacetylase (HDAC) inhibitor. Homo sapiens
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
assess the efficacy of ST7612AA1 oral pan-histone deacetylase inhibitor (HDACi), with respect to various solid and haematological tumors, and to characterize its mechanism of action Overall design: GEP analysis of two lymphoma cell lines with and without treatment
创建时间：
2014-10-17
